San Francisco confirms first case of Clade 1 Mpox
舊金山確診首例第一分支猴痘病例
On April 14, 2026, the San Francisco Department of Public Health confirmed the city's first case of Clade I mpox.
2026年4月14日，舊金山公共衛生局確認了該市首例第一分支(Clade I)猴痘病例。
The patient, an unvaccinated adult, required hospitalization but is currently recovering.
該名患者為一名未接種疫苗的成年人，曾需住院治療，目前正在康復中。
Health officials note that the virus was transmitted via close contact with an international traveler.
衛生官員指出，該病毒是透過與一名國際旅客的密切接觸而傳播。
While Clade I—which is linked to outbreaks in parts of Africa—is considered more severe than the Clade II variant seen in the 2022 US outbreak, the overall risk to the general public remains low.
雖然第一分支(Clade I)—與非洲部分地區的疫情爆發有關—被認為比2022年美國疫情中出現的第二分支(Clade II)變異株更為嚴重，但對一般大眾的整體風險仍然很低。
Medical experts stress that the JYNNEOS vaccine is effective against both clades and strongly advise those at higher risk to complete their two-dose series.
醫學專家強調，JYNNEOS疫苗對這兩種分支皆有效，並強烈建議高風險族群完成兩劑系列接種。
Clinicians are also urged to remain alert for potential cases in patients with recent international travel history.
臨床醫生也被敦促對近期有國際旅遊史的患者保持警惕。
